DK1720972T3 - Fremgangsmåde til celledyrkning ved hjælp af fortløbende perfusion og vekslende tangentialt flow - Google Patents

Fremgangsmåde til celledyrkning ved hjælp af fortløbende perfusion og vekslende tangentialt flow

Info

Publication number
DK1720972T3
DK1720972T3 DK05715787.7T DK05715787T DK1720972T3 DK 1720972 T3 DK1720972 T3 DK 1720972T3 DK 05715787 T DK05715787 T DK 05715787T DK 1720972 T3 DK1720972 T3 DK 1720972T3
Authority
DK
Denmark
Prior art keywords
tangential flow
cell cultivation
continuous perfusion
alternative tangential
alternative
Prior art date
Application number
DK05715787.7T
Other languages
English (en)
Inventor
Maike Wübben
Martin Jose Manuel Coco
John Crowley
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34961830&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1720972(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Application granted granted Critical
Publication of DK1720972T3 publication Critical patent/DK1720972T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/16—Yeasts; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M3/00—Tissue, human, animal or plant cell, or virus culture apparatus
    • C12M3/06—Tissue, human, animal or plant cell, or virus culture apparatus with filtration, ultrafiltration, inverse osmosis or dialysis means
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M25/00—Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
    • C12M25/10—Hollow fibers or tubes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
    • C12M29/10—Perfusion
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/44—Means for regulation, monitoring, measurement or control, e.g. flow regulation of volume or liquid level
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2521/00—Culture process characterised by the use of hydrostatic pressure, flow or shear forces
DK05715787.7T 2004-03-05 2005-03-04 Fremgangsmåde til celledyrkning ved hjælp af fortløbende perfusion og vekslende tangentialt flow DK1720972T3 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP04075703 2004-03-05
EP04075702 2004-03-05
EP04077657 2004-09-27
EP04077656 2004-09-27
PCT/EP2005/002374 WO2005095578A1 (en) 2004-03-05 2005-03-04 Process for cell culturing by continuous perfusion and alternating tangential flow

Publications (1)

Publication Number Publication Date
DK1720972T3 true DK1720972T3 (da) 2014-04-14

Family

ID=34961830

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05715787.7T DK1720972T3 (da) 2004-03-05 2005-03-04 Fremgangsmåde til celledyrkning ved hjælp af fortløbende perfusion og vekslende tangentialt flow

Country Status (14)

Country Link
US (3) US8206981B2 (da)
EP (3) EP1720972B1 (da)
JP (6) JP2007525984A (da)
KR (1) KR101050585B1 (da)
CN (3) CN1930281A (da)
AU (1) AU2005229359C1 (da)
CA (1) CA2557046A1 (da)
DK (1) DK1720972T3 (da)
ES (1) ES2456015T3 (da)
IL (2) IL177724A (da)
PL (1) PL1720972T3 (da)
PT (1) PT1720972E (da)
SI (1) SI1720972T1 (da)
WO (1) WO2005095578A1 (da)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1720972T3 (pl) 2004-03-05 2014-06-30 Dpx Holdings Bv Proces hodowli komórek poprzez ciągłą perfuzję i zmienny przepływ styczny
WO2007097260A1 (ja) 2006-02-24 2007-08-30 Toray Industries, Inc. 化学品の製造方法、および、連続発酵装置
EP1870450A1 (en) * 2006-06-21 2007-12-26 DSMIP Assets B.V. Process for the culturing of E1-immortalized HER cells
PT2634243T (pt) * 2006-07-14 2017-12-18 Patheon Holdings I B V Método para melhorar a cultura de células
AU2011211462C1 (en) * 2006-07-14 2015-01-22 Dpx Holdings B.V. Improved process for the culturing of cells
EP2014760A1 (en) 2007-06-13 2009-01-14 CMC Biopharmaceuticals A/S A method for producing a biopolymer (e.g. polypeptide) in a continuous fermentation process
AU2008345231B2 (en) * 2007-12-27 2014-09-11 Takeda Pharmaceutical Company Limited Cell culture processes
WO2010003759A2 (en) * 2008-06-17 2010-01-14 Dsm Ip Assets B.V. Cell culturing method
CN105708862B (zh) 2008-09-02 2020-11-06 普拉里斯坦有限公司 来自胎盘组织的粘附细胞及其在治疗中的用途
US10041049B2 (en) * 2008-11-03 2018-08-07 Janssen Vaccines & Prevention B.V. Method for the production of adenoviral vectors
MX2011012648A (es) 2009-07-16 2012-01-12 Crucell Holland Bv Produccion de titulos elevados de poliovirus para la produccion de vacunas.
MX2012004222A (es) 2009-10-15 2012-06-08 Crucell Holland Bv Metodo para purificacion de particulas de adenovirus.
PL2488635T3 (pl) 2009-10-15 2014-04-30 Crucell Holland Bv Proces do oczyszczania adenowirusa z hodowli o dużej gęstości komórek
PT2501822T (pt) 2009-11-17 2017-10-18 Squibb & Sons Llc Métodos para produção de proteínas melhorada
CN102762721B (zh) * 2010-02-15 2015-03-11 克鲁塞尔荷兰公司 用于生产Ad26腺病毒载体的方法
US20120315696A1 (en) * 2010-02-15 2012-12-13 Alfred Luitjens METHOD FOR THE PRODUCTION OF Ad26 ADENOVIRAL VECTORS
WO2011144561A1 (en) 2010-05-18 2011-11-24 Crucell Holland B.V. Methods for welding ethylene vinyl acetate (eva) tubing, tubing obtained thereby and use of such tubing for sterile transfer of content into a bioreactor
WO2012045769A1 (en) * 2010-10-05 2012-04-12 Novo Nordisk Health Care Ag Process for protein production
CN103517919B (zh) * 2011-05-13 2016-11-16 欧克塔医药公司 在重组fviii的生产中提高真核细胞生产率的方法
SI2837680T1 (sl) * 2011-07-01 2020-07-31 Amgen Inc. Celična kultura sesalca
US10485869B2 (en) 2011-10-18 2019-11-26 Coherus Biosciences, Inc. Etanercept formulations stabilized with meglumine
EA028520B1 (ru) 2011-10-18 2017-11-30 Кохерус Байосайенсис, Инк. Препараты этанерцепта, стабилизированные меглюмином
CN103305417A (zh) * 2012-03-07 2013-09-18 无锡药明康德生物技术有限公司 进行蛋白生产的高产量反应器及其生产方法和应用
GB201211256D0 (en) * 2012-06-25 2012-08-08 Glaxosmithkline Biolog Sa Fermentation process
AU2013290289B2 (en) 2012-07-09 2018-03-29 Coherus Biosciences, Inc. Etanercept formulations exhibiting marked reduction in sub-visible particles
CN104902914B (zh) 2012-09-11 2019-01-01 科荣生生物科学公司 高纯度和优异产量的正确折叠的依那西普
EP2900804B1 (en) * 2012-09-27 2019-09-18 GE Healthcare Bio-Sciences AB Tangential flow perfusion system
TWI637057B (zh) 2012-11-09 2018-10-01 拜爾沙納有限公司 具交替生物反應器用途之不連續進料批次製程
JP6742902B2 (ja) * 2013-03-15 2020-08-19 ジェンザイム・コーポレーション 高密度細胞バンキングの方法
DK2976418T3 (da) 2013-03-19 2021-01-11 Cmc Biologics As Fremgangsmåde til fremstilling af et produkt (f.eks. polypeptid) i en kontinuerlig cellekulturfermenteringsproces
KR20150133833A (ko) * 2013-03-26 2015-11-30 코히러스 바이오사이언시즈, 인코포레이티드 단백질 생산 방법
US9790465B2 (en) 2013-04-30 2017-10-17 Corning Incorporated Spheroid cell culture well article and methods thereof
CN113444620B (zh) * 2013-09-16 2024-03-29 建新公司 用于处理细胞培养物的方法和系统
BR112016006063A2 (pt) 2013-09-30 2017-08-01 Crucell Holland Bv método para clarificação de uma colheita de cultura celular em bruto
CN103525756B (zh) * 2013-10-23 2015-04-08 南京农业大学 一种原代鸡肝细胞的分离培养方法
US20160289633A1 (en) * 2013-12-20 2016-10-06 Biogen Ma Inc. Use of Perfusion Seed Cultures to Improve Biopharmaceutical Fed-Batch Production Capacity and Product Quality
JP6474420B2 (ja) * 2014-01-29 2019-02-27 アムジエン・インコーポレーテツド 組換えタンパク質のグリコシル化を調節するためのｎ−グリコシル化経路制御因子の過剰発現
EP3107934A4 (en) * 2014-02-17 2017-10-18 Advantech Bioscience Farmacêutica Ltda Enhancement of recombinant protein expression using a membrane-based cell retention system
EP3152317B1 (en) 2014-06-04 2019-01-02 Amgen Inc. Methods for harvesting mammalian cell cultures
PL3172317T3 (pl) 2014-07-24 2019-10-31 Janssen Vaccines & Prevention Bv Sposób oczyszczania wirusa polio z hodowli komórkowych
JP6530171B2 (ja) * 2014-09-09 2019-06-12 旭化成メディカル株式会社 培養産生物の回収方法
EP3212760A1 (en) 2014-10-29 2017-09-06 Corning Incorporated Perfusion bioreactor platform
WO2016069895A1 (en) 2014-10-29 2016-05-06 Corning Incorporated Cell culture insert
US10092888B2 (en) 2014-11-07 2018-10-09 Genesis Technologies, Llc Linear reciprocating actuator
WO2016128361A1 (en) * 2015-02-09 2016-08-18 Univercells Nv System, apparatus and method for the production of cells and/or cell products
US10358626B2 (en) 2016-04-12 2019-07-23 Artemis Biosystems, Inc. Perfusion filtration systems
US11261416B2 (en) 2016-04-14 2022-03-01 Trizell Ltd. Fixed-bed bioreactor with constant-flow pump / tubing system
CA3021070A1 (en) 2016-04-14 2017-10-19 Trizell Ltd. Fixed-bed bioreactor with constant-flow pump/tubing system
CN109072154A (zh) * 2016-04-15 2018-12-21 勃林格殷格翰国际公司 细胞保留装置和方法
KR20190009810A (ko) 2016-06-30 2019-01-29 후지필름 가부시키가이샤 세포 현탁액의 막분리 방법 및 세포 배양 장치
WO2018011805A2 (en) * 2016-07-11 2018-01-18 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Systems and methods for growing cells in vitro
PL3652291T3 (pl) 2017-07-14 2022-03-28 Corning Incorporated Naczynie do hodowli komórkowej
EP3652290B1 (en) 2017-07-14 2022-05-04 Corning Incorporated 3d cell culture vessels for manual or automatic media exchange
US11857970B2 (en) 2017-07-14 2024-01-02 Corning Incorporated Cell culture vessel
WO2019014610A1 (en) 2017-07-14 2019-01-17 Corning Incorporated CELL CULTURE CONTAINER FOR 3D CULTURE AND METHODS OF CULTURING 3D CELLS
WO2019049843A1 (ja) 2017-09-06 2019-03-14 富士フイルム株式会社 産生物の製造方法
KR20200047702A (ko) * 2017-09-15 2020-05-07 브리스톨-마이어스 스큅 컴퍼니 관심 폴리펩티드 대규모 생산 동안의 온라인 바이오매스 정전용량 모니터링
CN111344558A (zh) 2017-10-06 2020-06-26 龙沙有限公司 使用拉曼光谱法自动控制细胞培养
CN111212899A (zh) 2017-10-16 2020-05-29 里珍纳龙药品有限公司 灌注生物反应器及相关使用方法
EP3724229A1 (en) * 2017-12-11 2020-10-21 Amgen Inc. Continuous manufacturing process for bispecific antibody products
KR20220128673A (ko) * 2018-03-08 2022-09-21 리플리겐 코포레이션 탄젠셜 유동 깊이 여과 시스템 및 이를 이용한 여과 방법
CN110241012B (zh) * 2018-03-09 2022-11-01 嘉和生物药业有限公司 一种生物大分子上游分阶段截留的生产方法、生产模块及在生产中的应用
WO2019181234A1 (ja) * 2018-03-19 2019-09-26 富士フイルム株式会社 生産物の製造方法
WO2019227095A1 (en) 2018-05-25 2019-11-28 Repligen Corporation Tangential flow filtration systems and methods
CN108504562A (zh) * 2018-06-21 2018-09-07 江苏澳创生物科技有限公司 一种发酵生产l-苏氨酸的系统及其应用
WO2020013851A1 (en) 2018-07-13 2020-01-16 Corning Incorporated Fluidic devices including microplates with interconnected wells
CN111051493B (zh) 2018-07-13 2023-11-03 康宁股份有限公司 具有稳定器装置的细胞培养容器
EP3649226B1 (en) 2018-07-13 2022-04-06 Corning Incorporated Microcavity dishes with sidewall including liquid medium delivery surface
WO2020165873A1 (en) * 2019-02-15 2020-08-20 Oncosimis Biotech Private Limited Method and system for enhanced continuous production, secretion and separation of recombinant polypeptides from bacteria
CA3144125A1 (en) * 2019-07-16 2021-01-21 Haihong Sun Cell culture method based on high-density and continuous inoculation and use thereof
US20230287322A1 (en) 2020-07-28 2023-09-14 Seagen Inc. Methods and systems for producing polypeptides

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US54544A (en) * 1866-05-08 Improvement in low-water detecters
JPS61199788A (ja) 1985-02-28 1986-09-04 Mitsubishi Rayon Co Ltd 醗酵生成物の分離濃縮方法及び連続醗酵方法
US5286646A (en) 1985-11-25 1994-02-15 Boehringer Mannheim Gmbh Method for mammalian cell culture
GB8617646D0 (en) 1986-07-18 1986-08-28 Manchester Inst Science Tech Recovery of biological material
US4806484A (en) 1987-08-07 1989-02-21 Igb Products, Ltd. Perfusion airlift bioreactor
JPH0797982B2 (ja) 1987-09-24 1995-10-25 東洋紡績株式会社 細胞培養装置
US4921792A (en) 1987-11-27 1990-05-01 Miles Inc. Continuous cell dispersion, cultivation and substance recovery process
JPH01243985A (ja) 1988-03-25 1989-09-28 P C C Technol:Kk 植物器官の培養法及びその培養槽
US5595909A (en) 1988-05-23 1997-01-21 Regents Of The University Of Minnesota Filter device
EP0343635B1 (en) 1988-05-25 1994-08-24 Teijin Limited Process for continuously culturing adherent animal cells
JPH02113896A (ja) * 1988-10-24 1990-04-26 Snow Brand Milk Prod Co Ltd ヒト抗リシンモノクローナル抗体およびそれを分泌するハイブリドーマ
US5019512A (en) 1989-03-17 1991-05-28 Baxter International Inc. Spin filter for removing substantially cell-free culture medium from suspension cell culture system
JPH0541984A (ja) * 1990-09-07 1993-02-23 Dow Chem Co:The 攪拌容器における中空繊維においての細胞の増殖
US5256294A (en) 1990-09-17 1993-10-26 Genentech, Inc. Tangential flow filtration process and apparatus
GB9118664D0 (en) 1991-08-30 1991-10-16 Celltech Ltd Cell culture
JPH05153973A (ja) 1991-12-03 1993-06-22 Hitachi Ltd 細胞培養方法及び装置
US6204000B1 (en) 1995-04-28 2001-03-20 The United States Of America As Represented By The Department Of Health And Human Services Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1
JP2752918B2 (ja) * 1995-05-16 1998-05-18 ユーエイチティー株式会社 動物細胞のマイクロキャリア培養法
US6001585A (en) 1997-11-14 1999-12-14 Cellex Biosciences, Inc. Micro hollow fiber bioreactor
JP2997771B2 (ja) * 1998-06-29 2000-01-11 金沢大学長 細胞の懸濁培養方法
US6103526A (en) 1998-10-08 2000-08-15 Protein Sciences Corporation Spodoptera frugiperda single cell suspension cell line in serum-free media, methods of producing and using
US8026096B1 (en) * 1998-10-08 2011-09-27 Protein Sciences Corporation In vivo active erythropoietin produced in insect cells
US6667176B1 (en) 2000-01-11 2003-12-23 Geron Corporation cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
CA2252972C (en) 1998-11-26 2012-09-18 National Research Council Of Canada Serum-free production of recombinant proteins and adenoviral vectors
DK1147180T3 (da) 1999-01-26 2009-03-30 Schering Plough Ltd Opformering af bovin coronavirus i CHO-celler (kinesisk hamsterovarie)
US6855544B1 (en) 1999-04-15 2005-02-15 Crucell Holland B.V. Recombinant protein production in a human cell
CN100457914C (zh) 1999-04-15 2009-02-04 荷兰克鲁塞尔公司 用编码腺病毒e1蛋白的序列在人体细胞中生产重组蛋白
EP1103610A1 (en) 1999-11-26 2001-05-30 Introgene B.V. Production of vaccines from immortalised mammalian cell lines
JP2001149099A (ja) 1999-11-26 2001-06-05 Olympus Optical Co Ltd 染色体異常解析のための有核細胞の標本作製方法
US6544424B1 (en) 1999-12-03 2003-04-08 Refined Technology Company Fluid filtration system
US6168941B1 (en) 2000-04-07 2001-01-02 Genvec, Inc. Method of producing adenoviral vector stocks
JP4138209B2 (ja) 2000-06-29 2008-08-27 エーザイ・アール・アンド・ディー・マネジメント株式会社 プラバスタチン含有組成物
JP2002113896A (ja) 2000-10-05 2002-04-16 Seiko Epson Corp 画像形成装置
ATE422216T1 (de) 2001-04-17 2009-02-15 Seiren Kabushiki Kaisha Mediumzusätze und medien für tierzellkulturen
DE10120835C2 (de) 2001-04-27 2003-04-10 Sifin Inst Fuer Immunpraeparat Verfahren zur Herstellung von monoklonalen Antikörpern
CA2351156A1 (en) 2001-07-04 2003-01-04 Peter W. Zandstra A bioprocess for the generation of pluripotent cell derived cells and tissues
DK1451290T3 (da) * 2001-08-31 2011-04-26 Bayer Schering Pharma Ag Indretning og fremgangsmåde til udførelse af fermentering af høj celledensitet
JP3968347B2 (ja) 2001-09-05 2007-08-29 ヤマサ醤油株式会社 糖尿病性神経障害用医薬組成物
WO2003025158A1 (en) 2001-09-14 2003-03-27 Medcell Biologics, Inc. Oxygen enriched bioreactor and method of culturing cells
JP2003219873A (ja) 2002-01-24 2003-08-05 Japan Science & Technology Corp サケ科キングサーモン由来の不死化細胞
US20030186335A1 (en) 2002-03-28 2003-10-02 National Institute Of Advanced Industrial Science And Technology Monoclonal antibodies, hybridomas, cell isolation method, isolated cells and immunological diagnostic method
DE10237082B4 (de) 2002-08-09 2014-12-31 Sartorius Stedim Biotech Gmbh Verfahren und Vorrichtung zur biotechnologischen Herstellung von Wertstoffen
BRPI0409895B8 (pt) 2003-05-09 2021-05-25 Crucell Holland Bv método de cultura de células derivadas de células per.c6 capazes de crescer em suspensão para aumentar o rendimento de produto das referidas células
JP2005041984A (ja) 2003-07-22 2005-02-17 Shin Kobe Electric Mach Co Ltd 水架橋ポリオレフィン製シートの製造法
PL1720972T3 (pl) 2004-03-05 2014-06-30 Dpx Holdings Bv Proces hodowli komórek poprzez ciągłą perfuzję i zmienny przepływ styczny
PT2634243T (pt) 2006-07-14 2017-12-18 Patheon Holdings I B V Método para melhorar a cultura de células
JP2008308560A (ja) 2007-06-13 2008-12-25 Tohcello Co Ltd 表面防汚性複合フィルムの製造方法

Also Published As

Publication number Publication date
JP2017225443A (ja) 2017-12-28
CN1930281A (zh) 2007-03-14
WO2005095578A1 (en) 2005-10-13
US20130266985A1 (en) 2013-10-10
JP2014128272A (ja) 2014-07-10
JP5719947B2 (ja) 2015-05-20
US9260695B2 (en) 2016-02-16
AU2005229359B2 (en) 2009-01-08
US20080131934A1 (en) 2008-06-05
AU2005229359C1 (en) 2011-07-28
EP1720972A1 (en) 2006-11-15
EP2308958A2 (en) 2011-04-13
EP1720972B1 (en) 2014-01-08
US8206981B2 (en) 2012-06-26
AU2005229359A1 (en) 2005-10-13
IL205606A (en) 2011-08-31
ES2456015T3 (es) 2014-04-21
IL177724A0 (en) 2006-12-31
PT1720972E (pt) 2014-04-07
CN104593277A (zh) 2015-05-06
SI1720972T1 (sl) 2014-06-30
EP2540815A1 (en) 2013-01-02
CA2557046A1 (en) 2005-10-13
CN104388324A (zh) 2015-03-04
PL1720972T3 (pl) 2014-06-30
KR20070022221A (ko) 2007-02-26
JP2011125348A (ja) 2011-06-30
KR101050585B1 (ko) 2011-07-19
IL177724A (en) 2011-01-31
EP2308958A3 (en) 2011-08-10
JP2007525984A (ja) 2007-09-13
US20140087424A1 (en) 2014-03-27
JP2016039817A (ja) 2016-03-24
JP2012090632A (ja) 2012-05-17

Similar Documents

Publication Publication Date Title
DK1720972T3 (da) Fremgangsmåde til celledyrkning ved hjælp af fortløbende perfusion og vekslende tangentialt flow
DK1778829T3 (da) Direkte inokuleringsfremgangsmåde ved anvendelse af frosne koncentrerede kulturer og tilhørende indretning
DK1659398T3 (da) Fremgangsmåde til at analysere hæmoglobin ved hjælp af kapillær elektroforese, kit til kqpillæg elektroforese og avendelse af flowretarger i en sådan fremgangsmåde
DK1974017T4 (da) Midler og fremgangsmåder til at påvirke stabiliteten af antistof producerende celler
IS8582A (is) Notkun á dýptarsíun ásamt með samfelldri afskiljun til að fá tærar ræktir af spendýrafrumum
DK1948852T3 (da) Hovedelektrode og fremgangsmåde til dannelse af hovedelektroden
DK1791791T3 (da) Fremgangsmåder og sammensætninger til behandling af vand
DK1755743T3 (da) Beta-hydroxybutyrat og derivater til behandling af depression og angst
DK1667986T3 (da) Acetonesolvat af dimethoxydocetaxel og fremgangsmåde til fremstilling heraf
DK1524710T3 (da) Tynd batteristruktur, batterienhed og fremgangsmåde til fremstilling af batterienhed
DK2573166T3 (da) Fremgangsmåder til fremstilling af T-celler til celleterapi
DK1756536T3 (da) Fremgangsmåde og system til vurdering af prøver
DK2275648T3 (da) System og fremgangsmåde til forstærkning af turbineudgangseffekt
DK1838874T3 (da) Fremgangsmåder til regulering af stamceller
DK1817554T3 (da) Fremgangsmåde og indretning til bestemmelse af strømningstryk ved anvendelse af tæthedsinformation
DK1896564T3 (da) Fremgangsmåde og indretning til celledyrkning ved hjælp af bølgebevægelse
DK2578685T3 (da) Rna indeholende modificerede nukleosider og fremgangsmåder til anvendelse deraf
DK1776181T3 (da) System og fremgangsmåde til fluidtilførsel
DK1581487T3 (da) Fremgangsmåder og forbindelser til produktion af dipeptidylpeptidase iv-inhibitorer og mellemprodukter deraf
DK2959774T3 (da) Fremgangsmåde til kryokonservering af sædceller
DK1830838T3 (da) Sammensætninger og fremgangsmåder til behandling af neoplastiske sygdomme
DK2030476T3 (da) Fremgangsmåde og system til forbedring af forståeligheden af lyde
DK1971555T3 (da) Bioreaktor og fremgangsmåde til biologisk oprensning af vand
DK2068930T3 (da) Sammensætninger og fremgangsmåder under anvendelse af anti-CS1-antistoffer til at behandle multiple myelomer
FR2873694B1 (fr) Nouveaux aza-indoles inhibiteurs de la mtp et apob